Symposium on the role of SGLT2i in tackling cardiorenal risk in diabetes

15' education - Oct. 28, 2021 - Prof. Melanie Davies, MD - Leicester, UK and prof. Nikolaus Marx, MD - Aachen, Germany - Online CME

Educational information

This accredited symposium " Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia" was held during the virtual EASD 2021.

Faculty

Melanie Davies, MD, is Professor of Diabetes Medicine at the University of Leicester, UK.

Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant received from Boehringer Ingelheim / Lilly.

Click here for the video of Melanie Davies Click here for the video of Nicolaus Marx

Online-CME

This is available as accredited online CME on coursepath for members. Click the button below to enroll:

Enroll

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.